The role of microRNAs in 5‐FU resistance of colorectal cancer: Possible mechanisms

Authors:
Publisher website
Google Scholar
Abstract
Colorectal cancer (CRC) is one of the most common cancers globally. Despite recent advances in therapeutic approaches, this cancer continues to have a poor prognosis, particularly when diagnosed late. 5‐Fluorouracil (5‐FU) has been commonly prescribed for patients with CRC, but resistance to 5‐FU is one of the main reasons for failure in the treatment of this condition. Recently, microRNAs (miRNAs) have been established as a means of modifying the signaling pathways involved in initiation and progression of CRC and their role as oncogene or tumor suppressor have been investigated in various studies. Moreover, miRNAs through various mechanisms play an important role in inducing tumor resistance or sensitivity to anticancer drugs. Detecting and targeting these mechanisms may be a new therapeutic approach. This review summarizes the current knowledge about the potential roles of miRNAs in 5‐FU resistance, with particular emphasis on molecular mechanism involved.
Funding Information
  • Mashhad University of Medical Sciences (950909)

This publication has 67 references indexed in Scilit: